Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1961 Aug 26;85(9):469–476.

The Effect of Persantin on Coronary Flow and Cardiac Dynamics *

Eric C Elliot
PMCID: PMC1848319  PMID: 13726418

Full text

PDF
476

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRACHFELD N., BOZER J., GORIN R. Action of nitroglycerin on the coronary circulation in normal and in mild cardiac subjects. Circulation. 1959 May;19(5):697–704. doi: 10.1161/01.cir.19.5.697. [DOI] [PubMed] [Google Scholar]
  2. BRAUNWALD E., SARNOFF S. J., CASE R. B., STAINSBY W. N., WELCH G. H., Jr Hemodynamic determinants of coronary flow: effect of changes in aortic pressure and cardiac output on the relationship between myocardial oxygen consumption and coronary flow. Am J Physiol. 1958 Jan;192(1):157–163. doi: 10.1152/ajplegacy.1957.192.1.157. [DOI] [PubMed] [Google Scholar]
  3. DOERNER J., WICK E. [Comparative studies on the efficacy of commonly-used coronary vasodilator agents in anesthetized and unanesthetized dogs]. Arzneimittelforschung. 1960 Aug;10:631–636. [PubMed] [Google Scholar]
  4. GRABNER G., KAINDL F., KRAUPP O. Die Wirkung von 2, 6-Bis(diaethanolamino)-4, 8-dipiperidino-pyrimido(5,4-d)-pyrimidin auf Herztätigkeit und Coronarkreislauf narkotisierter Hunde. Arzneimittelforschung. 1959 Jan;9(1):45–47. [PubMed] [Google Scholar]
  5. HOCKERTS T., BOGELMANN G. Untersuchungen über die Wirkung von 2, 6-Bis (diaethanolamino)-4, 8-dipiperidino-pyrimido(5, 4-d)pyrimidin auf Herz und Kreislauf. Arzneimittelforschung. 1959 Jan;9(1):47–49. [PubMed] [Google Scholar]
  6. HONIG C. R., TENNEY S. M., GABEL P. V. The mechanism of cardiovascular action of nitroglycerine. An example of integrated response during the unsteady state. Am J Med. 1960 Dec;29:910–923. doi: 10.1016/0002-9343(60)90073-5. [DOI] [PubMed] [Google Scholar]
  7. KADATZ R. Die pharmakologischen Eigenschaften der neuen coronarerweiternden Substanz 2,6-Bis(diaethanolamino)-4, 8-dipiperidino-pyrimido(5,4-d)pyrimidin. Arzneimittelforschung. 1959 Jan;9(1):39–45. [PubMed] [Google Scholar]
  8. Kety S. S., Schmidt C. F. THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES. J Clin Invest. 1948 Jul;27(4):476–483. doi: 10.1172/JCI101994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kountz W. B., Smith J. R. THE FLOW OF BLOOD IN THE CORONARY ARTERIES IN PATHOLOGICAL HEARTS. J Clin Invest. 1938 Mar;17(2):147–152. doi: 10.1172/JCI100937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MORRISON R. T. Some applications of statistics to medical research. Can Med Assoc J. 1961 Mar 18;84:591–concl. [PMC free article] [PubMed] [Google Scholar]
  11. PABST H. W. Uber die Wirkung einer neuen coronarerweiternden Substanz: 2, 6-Bis (diäthanolamino)-4, 8-dipiperidino-pyrimido (5,4-d)pyrimidin. Med Klin. 1959 Feb 13;54(7):257–260. [PubMed] [Google Scholar]
  12. PHEMISTER J. C. Epilepsy and car-driving. Lancet. 1961 Jun 10;1(7189):1276–1277. doi: 10.1016/s0140-6736(61)92782-9. [DOI] [PubMed] [Google Scholar]
  13. SEELY R. D., NERLICH W. E., GREGG D. E. A comparison of cardiac output determined by the Fick procedure and a direct method using the rotameter. Circulation. 1950 Jun;1(6):1261–1266. doi: 10.1161/01.cir.1.6.1261. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES